ClinicalTrials.gov · NCT07906041 · Enrolling by invitation
Tirzepatide and Organ-specific Biological Aging
Registry record
NCT07906041 on ClinicalTrials.gov. The registry's last update to this record was 2 November 2026.
Verification record
5 checked · 0 company says · 0 reported · 0 not found · 0 not yet checked
- Title as registered Tirzepatide and Organ-specific Biological Aging Checked Source clinicaltrials.gov Brief title as registered. Checked
- Sponsor Atria Research and Global Health Institute (ARGHI) Checked Source clinicaltrials.gov Lead sponsor as registered. Checked
- Intervention Tirzepatide Checked Source clinicaltrials.gov Intervention names as registered. Checked
- Primary outcome as registered Change in Proteomic Brain Age Gap From Baseline to Month 6 Checked Source clinicaltrials.gov Primary outcome measure(s) as registered. Checked
- Status Enrolling by invitation Checked Source clinicaltrials.gov Overall status as registered; registry last update 2026-11-02. Checked
Check history: NCT07906041 was last read on the registry on November 14, 2026. No earlier checks are recorded. How records are checked.
Corrections: none recorded for this trial. To ask for one, write to [email protected] with the registry number; every correction is checked against the registry record before the record changes.
As registered
- Sponsor: Atria Research and Global Health Institute (ARGHI)
- Phase: Phase 2
- Status: Enrolling by invitation
- Intervention: Tirzepatide
- Primary outcome: Change in Proteomic Brain Age Gap From Baseline to Month 6
- Countries: United States
- Start: October 2026
- Completion (estimated): September 2028
Results
No results were posted on the registry on the date checked. The Atlas does not summarize findings.